Organogenesis Holdings (ORGO) EPS (Weighted Average and Diluted) (2018 - 2026)

Organogenesis Holdings' EPS (Weighted Average and Diluted) history runs 9 years deep, the most recent figure standing at -$0.44 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) fell 158.82% year-over-year to -$0.44; the TTM figure through Mar 2026 stood at -$0.16 (up 5.88% YoY), while the FY2025 annual figure was $0.15, up 1600.0% from the prior year.
• EPS (Weighted Average and Diluted) was -$0.44 for Q1 2026 at Organogenesis Holdings, down from $0.27 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.27 in Q4 2025 to a low of -$0.44 in Q1 2026.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.01 across 5 years, with a median of $0.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) surged 1133.07% in 2023, then plunged 750.0% in 2025.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.06 in 2022, then sank by 107.13% to -$0.0 in 2023, then jumped by 1034.84% to $0.04 in 2024, then surged by 575.0% to $0.27 in 2025, then sank by 262.96% to -$0.44 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.44 (Q1 2026), $0.27 (Q4 2025), and $0.11 (Q3 2025), per Business Quant data.